This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Oncology

mRNA-4157/V940 vaccine effective in advanced melanoma
mRNA-4157/V940 vaccine effective in advanced melanoma
Cannabidiol of no additional value for symptom distress reduction in advanced cancer
Cannabidiol of no additional value for symptom distress reduction in advanced cancer
Zanubrutinib improves progression-free survival in relapsed lymphocytic leukaemia
Zanubrutinib improves progression-free survival in relapsed lymphocytic leukaemia
Medical marijuana reduces opiate use among cancer patients
Medical marijuana reduces opiate use among cancer patients
Higher level of advanced colorectal cancer diagnosed during COVID-19
Higher level of advanced colorectal cancer diagnosed during COVID-19
Tisagenlecleucel effectiveness in paediatric leukaemia persists beyond 3 years
Tisagenlecleucel effectiveness in paediatric leukaemia persists beyond 3 years
Trastuzumab deruxtecan treatment of advanced gastric cancer recommended for EU approval 
Trastuzumab deruxtecan treatment of advanced gastric cancer recommended for EU approval 
Digital tumour infiltrating lymphocyte scoring predicts ICI benefit in lung cancer
Digital tumour infiltrating lymphocyte scoring predicts ICI benefit in lung cancer
Prostate cancer screening with MRI after PSA a cost-effective strategy
Prostate cancer screening with MRI after PSA a cost-effective strategy
Study suggests thyroid cancer increases coronary heart disease risk
Study suggests thyroid cancer increases coronary heart disease risk
Polygenic risk score and family history combined improve prostate cancer risk stratification
Polygenic risk score and family history combined improve prostate cancer risk stratification
Prophylactic irradiation of asymptomatic bone metastases reduces skeletal-related events
Prophylactic irradiation of asymptomatic bone metastases reduces skeletal-related events


Popular articles

Study shows HIV vaccine ineffective
RSV vaccine meets primary endpoint in older adults
Yescarta approved by NICE for relapsed/remitted lymphomas
Single low-dose CT scan helps predict future lung cancer risk
Dupixent approved for severe atopic dermatitis in children from 6 months




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora